11.05.18
Arcturus Therapeutics Ltd., an RNA medicines company, has opened its new San Diego based research and development facility. The 24,700-sq.-ft. San Diego facility, is more than twice the size of the company’s previous facility. It has approximatley 80 employees and is designed to help Arcturus continue development and commercialization of therapeutics for rare, infectious, fibrotic and respiratory diseases with significant unmet medical need.
“San Diego is recognized as a center of excellence for the biotechnology industry, and Arcturus has been located here since its inception,” said Joseph Payne, president and chief executive officer of Arcturus. “We appreciate the numerous benefits of being a member of the San Diego biotech community and the increased access to a world-class pool of qualified science professionals.”
“San Diego is recognized as a center of excellence for the biotechnology industry, and Arcturus has been located here since its inception,” said Joseph Payne, president and chief executive officer of Arcturus. “We appreciate the numerous benefits of being a member of the San Diego biotech community and the increased access to a world-class pool of qualified science professionals.”
